BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 18221956)

  • 21. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
    Lane BR; Abouassaly R; Gao T; Weight CJ; Hernandez AV; Larson BT; Kaouk JH; Gill IS; Campbell SC
    Cancer; 2010 Jul; 116(13):3119-26. PubMed ID: 20564627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-institutional validation of a symptom based classification for renal cell carcinoma.
    Patard JJ; Leray E; Cindolo L; Ficarra V; Rodriguez A; De La Taille A; Tostain J; Artibani W; Abbou CC; Guillé F; Chopin DK; Lobel B
    J Urol; 2004 Sep; 172(3):858-62. PubMed ID: 15310983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of thrombocytosis in renal cell carcinoma.
    Bensalah K; Leray E; Fergelot P; Rioux-Leclercq N; Tostain J; Guillé F; Patard JJ
    J Urol; 2006 Mar; 175(3 Pt 1):859-63. PubMed ID: 16469566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
    Javidan J; Stricker HJ; Tamboli P; Amin MB; Peabody JO; Deshpande A; Menon M; Amin MB
    J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality.
    Mejean A; Hopirtean V; Bazin JP; Larousserie F; Benoit H; Chrétien Y; Thiounn N; Dufour B
    J Urol; 2003 Sep; 170(3):764-7. PubMed ID: 12913693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
    Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
    Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification.
    Klatte T; Said JW; de Martino M; Larochelle J; Shuch B; Rao JY; Thomas GV; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2009 Apr; 181(4):1558-64; discussion 1563-4. PubMed ID: 19230920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
    Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.
    Donat SM; Salzhauer EW; Mitra N; Yanke BV; Snyder ME; Russo P
    J Urol; 2006 Jan; 175(1):46-52. PubMed ID: 16406867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
    J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.